Bret Stephens’ Pharmapologetics
Now, when the demand for both innovation and access is high, it’s time to think outside the box and reevaluate the relationship between pharmaceutical drugs and the patent system. Perhaps a prize system is in order, or maybe a formal guarantee from firms receiving BARDA grants that the drugs will not be patented.Featured Publications
Breaking the Fever: Inside One City’s Bold Plan to Stop the Spread of Violent Crime
Why Laws that Equate Drug Distribution to Murder Are Counterproductive
September Spotlight on Criminal Justice: What Works to Reduce Juvenile Crime?
Low-Energy Fridays: What Can Today’s Climate Movement Learn from a 25-Year-Old Analysis?